Inhibition of RM-1 prostate carcinoma and eliciting robust immune responses in the mouse model by using VEGF-M(2)-GnRH(3)-hinge-MVP vaccine.
- DOI
- 10.1038/s41435-017-0005-9
- Published
- 2019 Mar
- Container
- Genes and immunity
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41435-017-0005-9,
title = {Inhibition of RM-1 prostate carcinoma and eliciting robust immune responses in the mouse model by using VEGF-M(2)-GnRH(3)-hinge-MVP vaccine.},
author = {Wang Y and Alahdal M and Ye J and Jing L and Liu X and Chen H and Jin L and Cao R},
year = {2019},
journal = {Genes and immunity},
doi = {10.1038/s41435-017-0005-9},
url = {https://doi.org/10.1038/s41435-017-0005-9}
}RIS
TY - JOUR TI - Inhibition of RM-1 prostate carcinoma and eliciting robust immune responses in the mouse model by using VEGF-M(2)-GnRH(3)-hinge-MVP vaccine. AU - Wang Y AU - Alahdal M AU - Ye J AU - Jing L AU - Liu X AU - Chen H AU - Jin L AU - Cao R PY - 2019 JO - Genes and immunity DO - 10.1038/s41435-017-0005-9 UR - https://doi.org/10.1038/s41435-017-0005-9 ER -
APA
Y, W., M, A., J, Y., L, J., X, L., H, C., L, J., & R, C. (2019). Inhibition of RM-1 prostate carcinoma and eliciting robust immune responses in the mouse model by using VEGF-M(2)-GnRH(3)-hinge-MVP vaccine.. Genes and immunity. https://doi.org/10.1038/s41435-017-0005-9
Source records
- pubmed · retrieved 2026-09-25T23:27:16.474Z